Chronic myeloid leukemia;Krónikus myeloid leukaemia

Orvosi Hetilap

Volumn 146, Issue 6, 2005, Pages 243-247

  Udvardy, Miklós ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NONE   (Hungary)

Author keywords

Chronic myeloid leukemia; Philadelphia chromosoma

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; CYTARABINE; IMATINIB; INTERFERON; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; HUMAN; MORTALITY; PHILADELPHIA 1 CHROMOSOME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; ENZYME ACTIVATION; HUMANS; INTERFERONS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; SIGNAL TRANSDUCTION;

EID: 15744405742     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Angstreich, G. R., Smith, R., Douglas, B. és mtsa: Treatment options for chronic myeloid leukemia, imatinib versus interferon versus allogeneic transplant. Curr. Opin. Oncol., 2004, 16, 95-99.
2. Baron, F., Storb, R., Litlle, M., T.: Hematopoietic cell transplantation, five decades of progress. Arch. Med. Research, 2003, 34, 528-544.
3. Carella, A. M., Beltrami, G., Corsetti, M. T.: Autografting in chronic myeloid leukemia. Seminars in Hematology, 2003, 40, 72-79.
4. Cortes, J., Kantarijan, H.: Advanced phase chronic myeloid leukemia. Seminars in Hematology, 2003, 40, 79-87.
5. Demeter J., Lehoczky D., Poros A.: Az idült myeloid leukaemia (CML) kezelése. In Haematologiai betegségek kezelé sének módszertana. Szerk.: Lehoczky, D., Losonczy, H. Documed, Budapest. 2004, 80-87. old.
6. Goldman, J. M., Marin, D.: Management decisions in chronic myeloid leukemia. Seminars in Hematology, 2003, 40, 97-103.
7. Gratwohl, A., Baldomero, H., Urbano-Ispizua, A.: Transplantation in chronic myeloid leukaemia. Lancet, 2002, 359, 712-713.
8. Guilhot, F.: Indications for imatinib mesylate therapy and clinical management. The Oncologist, 2004, 9, 271-281.
9. Haferlach, T., Kern, W., Schnittger, S. és mtsa: Modem diagnostics in chronic myeloproliferative diseases. Ann. Hematol. 2004, 83, (Suppl. 1.) 59-61.
10. Hochhaus, A.: Imatinib mesylate in the treatment of chronic myelogeneous leukemia (CML) and gastrointestinal stromal tumors (GIST). Ann. Hematol. 2004, 83, (Suppl. 1.) 65-66.
11. Kantarjian, H. M., Obrien, S., Cortes, J. és mtsai: Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome positive chronic myelogeneous leukemia in the chronic phase. Cancer, 2003, 98, 2636-2642.
12. Molnár L., Losonczy H.: Új lehetoség a krónikus myeloid leukaemia kezelésében: specifikus tirozinkináz-inhibitor (STI571) Orv. Hetil., 2002, 143, 2379-2384.
13. Mughal, T. I., Goldman, J. M.: Chronic myeloid leukemia, current status and controversies. Oncology (Huntingt.) 2004, 18, 837-844.
14. Radich, J. P., Olavarria, E., Apperley, J. F.: Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. Hematol. Oncol. Clin. North Am., 2004, 18, 685-702.
15. Rák K.: A krónikus myeloid leukaemia mai kezelése, Orv. Hetil., 2003, 144, 405-412.
16. Ravandi, F., Kantarjian, H., Giles, F. és mtsa: New agents in acute myeloid leukemia and other myeloid disorders. Cancer, 2004, 100, 441-454.
17. Sausville, E. M.: Imatinib for chronic myelogenous leukemia, a 9 or 24 carat gold standard? Lancet, 2003, 361, 1400-1402.
18. Trelle, S. Higgins, G., Kober, T. és mtsa: Biannual report of the Cochrane Haematological Malignancies Group. J. Natl. Cancer Inst., 2004, 96, E2.
19. Vardiman, J. W., Harris, N. L., Brunning, R. D.: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002, 100, 2292-2302.